| Trial ID: | L4936 |
| Source ID: | NCT01339143
|
| Associated Drug: |
Galvus (Vildagliptin)
|
| Title: |
Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Oxidative Stress
|
| Interventions: |
DRUG: Galvus (vildagliptin)|DRUG: pioglitazone
|
| Outcome Measures: |
Primary: Glycemic Variability, 16 weeks | Secondary: Oxidative stress, 16 weeks|HbA1C, 16 weeks|hypoglycemia, 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Korea University Anam Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-04
|
| Completion Date: |
2013-05
|
| Results First Posted: |
|
| Last Update Posted: |
2011-05-09
|
| Locations: |
Korea University Anam Hospital, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01339143
|
